Feed on
Posts
Comments

Archive for the ‘Peer review’ Category

Last month the JAMA (Journal of the American medical association) published an article (issue 15, April 16) entitled Guest Authorship and Ghostwriting in Publications Related to Rofecoxib. The authors have analyzed about 250 documents from the pharmaceutical company Merck (archives from court documents) and articles (mostly clinical trials and reviews) about the anti-inflammatory drug Vioxx. Apparently [...]

Read Full Post »